In vitro activity of eravacycline and comparator agents against bacterial pathogens isolated from patients with cancer

BACKGROUND: Bacterial infections are common in patients with cancer, and many bacteria have developed resistance to currently used antibiotics. OBJECTIVES: We evaluated the in vitro activity of eravacycline (a recently developed fluorocycline) and comparators against bacterial pathogens isolated fro...

Descripción completa

Detalles Bibliográficos
Autores principales: Rolston, Kenneth, Gerges, Bahgat, Nesher, Lior, Shelburne, Samuel A, Prince, Randall, Raad, Issam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981869/
https://www.ncbi.nlm.nih.gov/pubmed/36875177
http://dx.doi.org/10.1093/jacamr/dlad020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981869/
https://www.ncbi.nlm.nih.gov/pubmed/36875177
http://dx.doi.org/10.1093/jacamr/dlad020

Ejemplares similares